Search Results - "Fearon, Douglas Thomas"

  • Showing 1 - 3 results of 3
Refine Results
  1. 1
    Blockade of CTLA-4 promotes the development of effector CD8+ T lymphocytes and the therapeutic effect of vaccination with an attenuated protozoan expressing NY-ESO-1

    Blockade of CTLA-4 promotes the development of effector CD8+ T lymphocytes and the therapeutic effect of vaccination with an attenuated protozoan expressing NY-ESO-1 by dos Santos, Luara Isabela, Galvão-Filho, Bruno, de Faria, Paula Cristina, Junqueira, Caroline, Dutra, Miriam Santos, Teixeira, Santuza Maria Ribeiro, Rodrigues, Maurício Martins, Ritter, Gerd, Bannard, Oliver, Fearon, Douglas Thomas, Antonelli, Lis Ribeiro, Gazzinelli, Ricardo Tostes

    Published in Cancer Immunology, Immunotherapy (01-03-2015)
    “…The development of cancer immunotherapy has long been a challenge. Here, we report that prophylactic vaccination with a highly attenuated Trypanosoma cruzi…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  2. 2
    Blockade of CTLA-4 promotes the development of effector CD8^sup +^ T lymphocytes and the therapeutic effect of vaccination with an attenuated protozoan expressing NY-ESO-1

    Blockade of CTLA-4 promotes the development of effector CD8^sup +^ T lymphocytes and the therapeutic effect of vaccination with an attenuated protozoan expressing NY-ESO-1 by Dos Santos, Luara Isabela, Galvão-filho, Bruno, de Faria, Paula Cristina, Junqueira, Caroline, Dutra, Miriam Santos, Teixeira, Santuza Maria; Ribeiro, Rodrigues, Maurício Martins, Ritter, Gerd, Bannard, Oliver, Fearon, Douglas Thomas, Antonelli, Lis Ribeiro, Gazzinelli, Ricardo Tostes

    Published in Cancer immunology, immunotherapy (01-03-2015)
    “…The development of cancer immunotherapy has long been a challenge. Here, we report that prophylactic vaccination with a highly attenuated Trypanosoma cruzi…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  3. 3
    Blockade of CTLA-4 promotes the development of effector CD8 super(+) T lymphocytes and the therapeutic effect of vaccination with an attenuated protozoan expressing NY-ESO-1

    Blockade of CTLA-4 promotes the development of effector CD8 super(+) T lymphocytes and the therapeutic effect of vaccination with an attenuated protozoan expressing NY-ESO-1 by Santos, Luara Isabela, Galvao-Filho, Bruno, Faria, Paula Cristina, Junqueira, Caroline, Dutra, Miriam Santos, Teixeira, Santuza Maria Ribeiro, Rodrigues, Mauricio Martins, Ritter, Gerd, Bannard, Oliver, Fearon, Douglas Thomas, Antonelli, Lis Ribeiro, Gazzinelli, Ricardo Tostes

    Published in Cancer Immunology, Immunotherapy (01-03-2015)
    “…The development of cancer immunotherapy has long been a challenge. Here, we report that prophylactic vaccination with a highly attenuated Trypanosoma cruzi…”
    Get full text
    Journal Article
    Save to List
    Saved in:

Search Tools: